Vest Financial LLC increased its position in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 0.5% in the second quarter, according to its most recent 13F filing with the SEC. The firm owned 367,748 shares of the company's stock after purchasing an additional 1,823 shares during the period. Vest Financial LLC's holdings in Procter & Gamble were worth $58,590,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in PG. Kingstone Capital Partners Texas LLC boosted its stake in shares of Procter & Gamble by 655,209.0% during the 2nd quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company's stock valued at $11,832,680,000 after buying an additional 76,017,350 shares during the period. Nuveen LLC acquired a new stake in shares of Procter & Gamble during the 1st quarter valued at $1,954,941,000. Price T Rowe Associates Inc. MD boosted its stake in shares of Procter & Gamble by 13.0% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company's stock valued at $3,660,737,000 after buying an additional 2,466,308 shares during the period. Invesco Ltd. boosted its stake in shares of Procter & Gamble by 19.8% during the 1st quarter. Invesco Ltd. now owns 13,493,604 shares of the company's stock valued at $2,299,580,000 after buying an additional 2,228,151 shares during the period. Finally, Valeo Financial Advisors LLC boosted its stake in shares of Procter & Gamble by 1,875.5% during the 2nd quarter. Valeo Financial Advisors LLC now owns 1,763,404 shares of the company's stock valued at $280,946,000 after buying an additional 1,674,139 shares during the period. Institutional investors and hedge funds own 65.77% of the company's stock.
Insider Activity
In other news, COO Shailesh Jejurikar sold 13,039 shares of the business's stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total transaction of $2,050,643.53. Following the transaction, the chief operating officer owned 28,036 shares in the company, valued at approximately $4,409,221.72. The trade was a 31.74% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Marc S. Pritchard sold 9,849 shares of the business's stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total transaction of $1,548,952.23. Following the transaction, the insider owned 182,422 shares in the company, valued at approximately $28,689,507.94. The trade was a 5.12% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 149,763 shares of company stock worth $23,421,279. Insiders own 0.20% of the company's stock.
Procter & Gamble Stock Down 0.6%
Procter & Gamble stock opened at $149.69 on Monday. The firm has a market cap of $350.34 billion, a price-to-earnings ratio of 22.99, a P/E/G ratio of 3.97 and a beta of 0.36. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.70 and a quick ratio of 0.49. Procter & Gamble Company has a fifty-two week low of $149.45 and a fifty-two week high of $180.43. The firm has a fifty day moving average price of $155.24 and a two-hundred day moving average price of $159.41.
Procter & Gamble (NYSE:PG - Get Free Report) last released its earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, topping analysts' consensus estimates of $1.42 by $0.06. The firm had revenue of $20.89 billion during the quarter, compared to analyst estimates of $20.79 billion. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The business's revenue was up 1.7% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.40 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, analysts forecast that Procter & Gamble Company will post 6.91 earnings per share for the current year.
Analyst Upgrades and Downgrades
A number of equities research analysts have issued reports on the stock. Bank of America decreased their target price on shares of Procter & Gamble from $180.00 to $174.00 and set a "buy" rating for the company in a research note on Wednesday, October 8th. Evercore ISI restated an "in-line" rating and set a $170.00 price target (down previously from $190.00) on shares of Procter & Gamble in a report on Monday, July 14th. Berenberg Bank raised their price target on shares of Procter & Gamble from $152.00 to $154.00 and gave the company a "hold" rating in a report on Wednesday, September 17th. Barclays cut their price target on shares of Procter & Gamble from $164.00 to $153.00 and set an "equal weight" rating on the stock in a report on Wednesday, October 1st. Finally, BNP Paribas Exane cut their price target on shares of Procter & Gamble from $177.00 to $172.00 and set an "outperform" rating on the stock in a report on Tuesday, September 23rd. Eleven equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company's stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $172.21.
Get Our Latest Report on Procter & Gamble
About Procter & Gamble
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Read More
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report